Faculty of Medicine, Alexandria University, Alexandria.
Faculty of Medicine, Al-Azhar University, Assiut.
Eur J Cancer Prev. 2022 May 1;31(3):293-300. doi: 10.1097/CEJ.0000000000000690.
This study aims to identify the risk factors for cardiovascular mortality in melanoma patients.
Data of melanoma patients were obtained from the Surveillance, Epidemiology, and End Results database. We used Person's chi-square test to assess the relationships between categorical variables. We used Kaplan-Meier test in the univariate analysis and Cox regression test for the multivariate analysis. Analyses were conducted using the SPSS software.
We analyzed data of 194 503 melanoma patients. Among them, 28 818 (14.8 %) died due to cardiovascular diseases. Cardiovascular-specific survival was higher in younger patients, women, married, localized disease, superficial spreading melanoma and in patients who had surgery. It was lower in patients who received chemotherapy or radiotherapy. The multivariate analysis revealed a higher risk of cardiovascular mortality in patients aged 50-64 years [hazard ratio (HR), 7.297; 95% confidence interval (CI), 6.68-7.97], patients aged ≥65 years (HR, 43.309; 95% CI, 39.706-47.240), men (HR, 1.535; 95% CI, 1.475-1.597), Blacks (HR, 1.29; 95% CI, 1.044-1.594), separated (HR, 1.286; 95% CI, 1.058-1.562), widowed (HR, 1.829; 95% CI, 1.706-1.961), patients with no or unknown history of chemotherapy (HR, 1.302; 95% CI, 1.071-1.583) or radiotherapy (HR, 1.477; 95% CI, 1.217-1.793) and patients with no surgery (HR, 1.468; 95% CI, 1.264-1.706).
In patients with melanoma, the risk of cardiovascular death is higher in older patients, men, Blacks, separated, widowed and patients with nodular or lentigo maligna melanoma. The risk is lower in married, patients with superficial spreading or acral lentiginous melanoma, and patients who had chemotherapy, radiotherapy or surgery.
本研究旨在确定黑色素瘤患者心血管死亡的风险因素。
从监测、流行病学和最终结果数据库中获取黑色素瘤患者的数据。我们使用 Person 的卡方检验来评估分类变量之间的关系。我们使用 Kaplan-Meier 检验进行单因素分析,使用 Cox 回归检验进行多因素分析。分析使用 SPSS 软件进行。
我们分析了 194503 名黑色素瘤患者的数据。其中,28818 名(14.8%)因心血管疾病死亡。年轻患者、女性、已婚、局限性疾病、浅表扩散型黑色素瘤和接受手术的患者心血管特异性生存率较高。接受化疗或放疗的患者生存率较低。多因素分析显示,50-64 岁患者(风险比[HR],7.297;95%置信区间[CI],6.68-7.97)、≥65 岁患者(HR,43.309;95%CI,39.706-47.240)、男性(HR,1.535;95%CI,1.475-1.597)、黑人(HR,1.29;95%CI,1.044-1.594)、离异(HR,1.286;95%CI,1.058-1.562)、丧偶(HR,1.829;95%CI,1.706-1.961)、无或未知化疗(HR,1.302;95%CI,1.071-1.583)或放疗(HR,1.477;95%CI,1.217-1.793)史以及无手术史的患者(HR,1.468;95%CI,1.264-1.706),心血管死亡风险较高。
在黑色素瘤患者中,年龄较大的患者、男性、黑人、离异、丧偶和结节性或恶性雀斑样黑色素瘤患者的心血管死亡风险较高。已婚、浅表扩散型或肢端雀斑样黑色素瘤患者以及接受化疗、放疗或手术的患者的风险较低。